Get the Stockscreener App
0.7134
0.94%
-0.0068
Pasithea Therapeutics Corp stock is traded at $0.7134, with a volume of 51,164.
It is down -0.94% in the last 24 hours and up +0.32% over the past month.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
See More
Previous Close:
$0.7202
Open:
$0.71
24h Volume:
51,164
Relative Volume:
0.39
Market Cap:
$5.28M
Revenue:
-
Net Income/Loss:
$-16.28M
P/E Ratio:
-0.0513
EPS:
-13.91
Net Cash Flow:
$-13.75M
1W Performance:
-9.58%
1M Performance:
+0.32%
6M Performance:
-34.55%
1Y Performance:
-87.70%
1-Day Range:
$0.695
$0.725
1-Week Range:
$0.695
$0.8001
52-Week Range:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Name
Pasithea Therapeutics Corp
Sector
Industry
Phone
(702) 514-4174
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.71 | 5.36M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.53 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.81 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.53 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
728.47 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
339.88 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Stock (KTTA) Latest News
Insider Buy: Is Pasithea Therapeutics Corp a speculative investmentJuly 2025 Rallies & Expert-Curated Trade Recommendations - خودرو بانک
Published on: 2025-09-18 05:47:09 - newser.com
Portfolio Update: Is Pasithea Therapeutics Corp. Equity Warrant impacted by rising ratesBull Run & Expert Approved Momentum Trade Ideas - خودرو بانک
Targets Report: Will Pasithea Therapeutics Corp. Equity Warrant benefit from sector rotation2025 Growth vs Value & Technical Confirmation Alerts - خودرو بانک
Order flow analysis tools used on Pasithea Therapeutics Corp. Equity Warrant2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Analyzing net buyer seller activity in Pasithea Therapeutics Corp.July 2025 Highlights & Entry Point Confirmation Signals - newser.com
Published on: 2025-09-16 21:08:09 - newser.com
Can Pasithea Therapeutics Corp. hit a new high this monthAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Decliners Report: Will Pasithea Therapeutics Corp. face regulatory challenges2025 Retail Activity & Step-by-Step Trade Execution Guides - خودرو بانک
Real time breakdown of Pasithea Therapeutics Corp. stock performance2025 Top Decliners & AI Driven Price Predictions - newser.com
Pasithea Therapeutics Approves Key Proposals at Annual Meeting - MSN
Profit Review: Is Pasithea Therapeutics Corp Equity Warrant stock a good dividend stockTake Profit & Breakout Confirmation Trade Signals - خودرو بانک
Surprises Report: Can Pasithea Therapeutics Corp disrupt its industryJuly 2025 Recap & Safe Entry Point Alerts - خودرو بانک
Published on: 2025-09-16 22:32:07 - خودرو بانک
Pasithea Therapeutics Expands Clinical Trials to South Korea - TipRanks
What MACD and RSI say about Pasithea Therapeutics Corp.Analyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Using R and stats models for Pasithea Therapeutics Corp. forecastingWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Institution Moves: Can Pasithea Therapeutics Corp. Equity Warrant deliver alphaJuly 2025 Review & AI Enhanced Execution Alerts - خودرو بانک
Real time pattern detection on Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients - GlobeNewswire
10,000 NF1 Patients: Pasithea's Next-Gen MEK Inhibitor Trial Launches at Korea's Largest Hospitals - Stock Titan
Pasithea Therapeutics Corp. stock trendline breakdown2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Hedge Fund Bets: Is Pasithea Therapeutics Corp.’s ROE strong enoughJuly 2025 Update & High Conviction Buy Zone Alerts - خودرو بانک
Is Pasithea Therapeutics Corp. a speculative investmentMarket Trend Summary & Precise Swing Trade Alerts - خودرو بانک
Tools to monitor Pasithea Therapeutics Corp. recovery probabilityTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Sell Signal: Does Pasithea Therapeutics Corp. have strong EBITDA marginsJuly 2025 Update & AI Powered Buy and Sell Recommendations - خودرو بانک
Strategies to average down on Pasithea Therapeutics Corp. Equity WarrantTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com
What recovery options are there for Pasithea Therapeutics Corp.July 2025 Sector Moves & Fast Gain Stock Tips - newser.com
Published on: 2025-09-16 05:59:05 - خودرو بانک
Rally Mode: Should you buy the dip on Pasithea Therapeutics CorpDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Price action breakdown for Pasithea Therapeutics Corp.Oil Prices & Reliable Entry Point Trade Alerts - newser.com
Weekly Recap: What is the Moat Score of Pasithea Therapeutics Corp Equity WarrantWeekly Stock Report & Breakout Confirmation Trade Signals - خودرو بانک
Fed Watch: Will Sempra outperform small cap indexesJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - خودرو بانک
Movement Recap: What is the long term forecast for Pasithea Therapeutics Corp stockEarnings Risk Report & Weekly Top Gainers Trade List - خودرو بانک
What to expect from Pasithea Therapeutics Corp. in the next 30 days2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
What earnings revisions data tells us about Pasithea Therapeutics Corp. Equity WarrantQuarterly Trade Review & Verified Entry Point Detection - newser.com
How high can Pasithea Therapeutics Corp. stock goTrade Risk Assessment & Weekly High Conviction Ideas - newser.com
Is Pasithea Therapeutics Corp. stock reversal real or fakeJuly 2025 PreEarnings & Long-Term Investment Growth Plans - newser.com
Published on: 2025-09-14 18:24:25 - newser.com
Is Pasithea Therapeutics Corp. stock entering bullish territoryPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-09-14 14:01:45 - newser.com
Is a relief rally coming for Pasithea Therapeutics Corp. Equity Warrant holdersEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Will Pasithea Therapeutics Corp. rebound enough to break evenJuly 2025 Big Picture & Weekly High Return Stock Forecasts - newser.com
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pasithea Therapeutics Corp Stock (KTTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
0.28%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):